使用Player FM应用程序离线!
The 2025 pharma forecast
Manage episode 462771876 series 3299609
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead.
The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise.
A little more on GOLD’s guests…
Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases.
Mercedes Diz has over 20 years’ experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen’s Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation.
Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world’s first operating room robot.
285集单集
Manage episode 462771876 series 3299609
Curious to discover what might lie ahead for industry in 2025? Join Isabel and Jade in this special episode of the EMJ GOLD podcast as they reflect on whether last year’s predictions for 2024 came true, while three special guests share their predictions and hopes for pharma in the year ahead.
The line-up includes Jennifer Schranz of Ipsen, Mercedes Diz of Almirall and EMJ’s own Dr Jonathan Sackier - all of whom share their predictions in their areas of expertise.
A little more on GOLD’s guests…
Jennifer Schranz is the Senior Vice President, Global Head of Rare Diseases at Ipsen, where she oversees the Rare Diseases therapy area with a focus on R&D strategy and execution. During her time at the business, she has led talented teams of scientists and fostered strong internal collaborations within the company, leveraging her clinical development expertise to advance Ipsen’s vision of addressing challenging rare diseases.
Mercedes Diz has over 20 years’ experience in the pharmaceutical industry, having graduated with a degree in Biochemistry and Molecular Biology from the Autonomous University of Madrid. She has worked in a number of different pharmaceutical companies, from J&J to Pfizer, and is also a keen member of the Healthcare Businesswomen’s Association. At Almirall, she leads portfolio strategy and commercial innovation for global brands, new products and digital and cultural transformation.
Dr Jonathan Sackier is Chairman at EMJ and the host of the EMJ podcast, where he utilises his experience as a physician to discuss the latest breakthroughs and challenges in the medical field with fellow practitioners and experts. Jonathan is a founding partner of many start-ups in the medical technology space and created the world’s first operating room robot.
285集单集
所有剧集
×欢迎使用Player FM
Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。